Tecan Group AG announced that Mukta Acharya, currently serving as President, Tecan Americas, has been appointed the new Head of the Life Sciences Business division and a member of the Management Board of the Tecan Group. She is expected to assume her new position on August 1, 2024. Dr. Klaus Lun, Head of the Life Sciences Business since 2017 and a member of the Management Board since 2013, has decided to leave the company to pursue other career opportunities.

Mukta Acharya joined Tecan in July 2022 as President, Tecan Americas, where she was responsible for the successful financial and market performance of the Life Sciences Business division in the company?s sales region. Mukta Acharya joined Tecan from Thermo Fisher Scientific, where she most recently served as Vice President and General Manager of the Single-use Flexible Solutions business. In this role, she drove the strategic growth of the global business, which spanned multiple manufacturing sites and thousands of employees worldwide.

She also oversaw product management, marketing, engineering, and business development across the organization's various business units. From 2010 to 2018, Mukta Acharya held leadership positions at CVS Health, most recently as Director, Enterprise Product Innovation & Management. Prior to that, she worked in management consulting.

She has a bachelor?s degree in Mechanical Engineering from India and a master?s degree in Engineering Management from Dartmouth College in the United States. Under Klaus Lun?s leadership, the Life Sciences Business division achieved significant growth and successfully navigated the challenges of the Covid-19 pandemic. Tecan?s Board of Directors and CEO would like to express their sincere gratitude to Klaus Lun for his strong engagement and important service of developing Tecan's Life Sciences Business and wish him all the best for the future.